Revelation Biosciences Warrant
REVBW
8 hedge funds and large institutions have $7.54M invested in Revelation Biosciences Warrant in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$473K |
| 2 |
LA
Linden Advisors
New York
|
+$463K |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$363K |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$239K |
| 5 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
+$182K |
Top Sellers
REVBW Hedge Fund Activity: Q4 2020 in Review
8 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q4 2020, worth a combined $7.54M.
Buyers outnumbered sellers: 8 funds opened new REVBW positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $473K.
- 8 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $7.54M of Revelation Biosciences Warrant stock for Q4 2020.
- 8 funds opened new Revelation Biosciences Warrant positions in Q4 2020 and 0 closed out, a net change of +8 holders.
- The largest Revelation Biosciences Warrant buyer in Q4 2020 was Hudson Bay Capital Management, an estimated $473K added.
Based on aggregated 13F filings for Q4 2020.